Multipotent stem cells in cardiac regenerative therapy

Regenerative Medicine

Volumn 3, Issue 2, 2008, Pages 189-198

  Karra, Ravi ^a   Wu, Sean M ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Division of Cardiology   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Adult stem cells; Cardiac development; Cardiac progenitor cells; Cardiac regeneration; Myocardial infarction

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL LINEAGE; CELL TYPE; CLINICAL TRIAL; DISEASE MODEL; EMBRYO CELL; GENE EXPRESSION; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HUMAN; IN VITRO STUDY; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; REGENERATION; REGENERATIVE MEDICINE; REVIEW; STEM CELL MOBILIZATION;

ADULT; ANIMALS; BONE MARROW CELLS; CLINICAL TRIALS AS TOPIC; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART; HUMANS; MULTIPOTENT STEM CELLS; REGENERATION;

EID: 42349108793     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.3.2.189     Document Type: Review

References (72)

1. Rosamond W, Flegal K, Friday G et al.: Heart Disease and Stroke Statistics - 2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115, e69-e171 (2007).
2. Korbling M, Estrov Z: Adult stem cells for tissue repair - a new therapeutic concept? N. Engl. J. Med. 349, 570-582 (2003).
3. Ferrari G, Cusella-De Angelis G, Coletta M et al.: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 1528-1530 (1998).
4. Petersen BE, Bowen WC, Patrene KD et al.: Bone marrow as a potential source of hepatic oval cells. Science 284, 1168-1170 (1999).
5. Eglitis MA, Mezey E: Hematopoietic, cells differentiate into both microglia and macroglia in the brains of adult ntice. Proc. Natl Acad. Sci. USA 94, 4080-4085 (1997).
6. Brazelton TR, Rossi FM, Keshet GI, Blau HM: From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290, 1775-1779 (2000).
7. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR: Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1779-1782 (2000).
8. Orlic D, Kajstura J, Chimenti S et al.: Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
9. Jackson K, Majka S, Wang H et al.: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin, Invest. 107, 1395-1402 (2001).
10. Orlic D, Kajstura J, Chimenti S et al.: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl Acad. Sci. USA 98, 10344-10349 (2001).
11. Amado L, Saliaris A, Schuleri K et al.: Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial Infarction. Proc. Natl. Acad. Sci. USA 102, 11474-11479 (2005).
12. Dai W, Hale S, Martin B et al.: Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112, 214-223 (2005).
13. Terada N, Hamazaki T, Oka M et al.: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545 (2002).
14. Alvarez-Dolado M. Pardal R, Garcia-Verdugo JM et al.: Fusion of bone-marrow-derived cells with Purkinje neurons, cardiamyocytes and hepatocytes. Nature 425, 968-973 (2003).
15. Oh H, Bradfute S, Galiardo T et al.: Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA 100, 12313-12318 (2003).
16. Nygren JM, Jovinge S, Breitbach M et al.: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10, 494-501 (2004).
17. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC: Haematopoietic stem cells adopt mature Haematopoietic fates in Ischaemic myocardium. Nature 428, 668-673 (2004).
18. Murry CE, Soonpaa MH, Reinecke H et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes In myocardial infarcts. Nature 428, 664-668 (2004).
19. Kajstura J, Rota M, Whang B et al.: Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ. Res. 96, 127-137 (2005).
20. Cowan CA, Atienza. J, Melton DA, Eggan K: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369-1373 (2005).
21. Grunewald M, Avraham I, Dor Y et al.: VEGF-Induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175-189 (2006).
22. Mirotsou M, Zhang Z, Deb A et al.: Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc. Natl Acad. Ski. USA 104, 1643-1648 (2007).
23. Gnecchi M, He H, Liang OD et al.: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchytnal stem cells. Nat. Med. 11, 367-368 (2005).
24. + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330-338 (2004).
25. Kajstura J, Leri A, Finato N, Di Loreto C, Beitrami CA, Anversa P: Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl Acad. Sci. USA 95, 8801-8805 (1998).
26. Beltrami AP, Urbanek K, Kajstura J et al.: Evidence that human cardiac myocytes divide after myocardial infarction. N Engl. J. Med. 344, 1750-1757 (2001).
27. Besmer P. Manova K, Duttlinger R et al.: The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Dev. Suppl. 125-137 (1993).
28. Beltrami AP, Barlucchi L, Torella D et al.: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776 (2003).
29. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA 100, 12313-12318 (2003).
30. Martin CM, Meeson AP, Robertson SM et al.: Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265, 262-275 (2004).
31. Murry CE, Reinecke H, Pabon LM: Regeneration gaps: observations on stem cell and cardiac repair. J. Am. Coll. Cardiol. 47, 1777-1785 (2606).
32. Yamanaka S: Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1, 39-49 (2007).
33. Bearzi C, Rota M, Hosoda T et al.: Human cardiac stem cells. Proc. Natl Acad. Sci. USA 104, 14068-14073 (2007).
34. Smith RR. Barile, Cho HC et al.: Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896-908 (2007).
35. Norol F, Merlet P, Isnard R et al.: Influence of mobilized stem cells on myocardial infarct repair inm a nonhuman primate model. Blood 102, 4361-4368 (2003)
36. Kang H, Kim H, Zhang S et al.:Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting In myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363, 751-756 (2004).
37. Valginaigli M, Rigolin G, Cittanti C et al.: Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile. Eur. Heart J. 26, 1838-1845 (2005).
38. Ince H, Petzch M, Kleine H et al.: Preservation from left ventricular remodeling by front-integrated revascularization and item cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112, 3097-3106 (2005).
39. Zohinhofer D, Ott I, Mehilli J et al.: Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295, 1003-1010 (2006).
40. Engelmann M, Theiss H, Hennig-Theiss C et al.: Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (granulocyte colony-stimulating factor ST-segment elevation myocardial infarction) trial. J Am. Coll. Cardiol. 48, 1712-1721 (2006).
41. Strauer BE, Brehm M, Zeus T et al.: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-1918 (2002).
42. Assmus B, Schachinger V, Teupe C et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106, 3009-3017 (2002).
43. Schachinger V, Assmus B, Britten MB et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J. Am. Coll. Cardiol. 44, 1690-1699 (2004).
44. Wollert KC, Meyer GP, Lotz J et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141-148 (2004).
45. Schachinger V, Erbs S, Elsasser A et al.: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. Med. 355, 1210-1221 (2006).
46. Assmus B, Honold J, Schachinger V et al.: Transcoronary transplantation of progenitor cells after myocardial infarctlon. N. Engl. J. Med. 355, 1222-1232 (2006).
47. Janssens S, Dubois C, Bogaert J et al.: Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367, 113-121 (2006).
48. Lunde K, Solheim S, Aakhus S et al.: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355, 1199-1209 (2006).
49. Meyer GP, Wollert KC, Lotz J et al.: Intracoronary bone marrow cell transfer after myocardial Infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113, 1287-1294 (2006).
50. Korbling M, Reuben JM, Gao H et al.: Recombinant human granulocyte-colony-stimulating factor mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion 46, 1795-1802 (2006).
51. Stamm C, Westphal B, Kleine HD et al.: Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45-46 (2003).
52. Tse H, Kwong Y, Chan J, Lo G, Ho C, Lau C: Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361, 47-49 (2003).
53. Losordo DW, Schatz RA, White CJ et al.: Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a Phase I/IIa double-blind, randomized controlled trial. Circulation 115, 3165-3172 (2007).
54. Perin EC, Dohmann HF, Borcjevic R et al.: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart more. Circulation 107, 2294-2302 (2003).
55. Penicka M, Horak J, Kobyika P et al.: Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocrdial infarction: a prematurely terminated randomized study. J. Am. Coll. Cardiol. 49, 2373-2374 (2007).
56. Villa A, Sanchez PL, Fernandez-Aviles F, For. the Terapia Celular Aplicada al Miocardio research group. Ventricular arrhythmias following intracoronary bone marrow stem cell transplantation. Europace 9(12), 1222-1223 (2007).
57. Wu SM, Fujiwara Y, Cibulsky SM et al.: Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127, 1137-1151 (2006).
58. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151-1165 (2006).
59. + cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell. 11, 723-732 (2006).
60. Solloway MJ, Harvey RP: Molecular pathways in myocardial development: a stem cell perspective. Cardiovasc. Res. 58, 264-277 (2003).
61. Saga Y, Kitajima S, Miyagawa-Tomita S: Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc. Med. 10, 345-352 (2000).
62. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 292, 1145-1147 (1998).
63. Wobus AM, Boheler KR: Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 85, 635-678 (2005).
64. Maltsev VA, Rohwedel J, Hescheler J. Wobus AM: Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech. Dev. 44, 41-50 (1993).
65. Laflamme MA, Chen KY, Naumova AV et al.: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015-1024 (2007).
66. van Laake LW, Passier R, Monshouwer-Kloots J et al.: Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. (2007) (In Press).
67. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
68. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317 (2007).
69. Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324 (2007).
70. Maherali N, Sridharan R, Xie W et al.: Directly reprogrammed fibroblasts show global epigenetic remodelling and widespread tissue contribution. Cell Stem Cell 1, 55-70 (2007).
71. Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult fibroblasts by defined factors. Cell 131 (5), 861-872 (2007).
72. Yu J, Vodyanik MA, Smuga, Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917-1920 (2007).